Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy.
Border
W A
WA
Noble
N A
NA
D000818:Animals; D003928:Diabetic Nephropathies / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D005355:Fibrosis; D006801:Humans; D012084:Renin-Angiotensin System / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*
D016212:Transforming Growth Factor beta